Histopathology during the COVID-19 pandemic: resilience through adaptation and innovation

Tim Bracey; Saimah Arif; Angela Mercy Ralte; Abeer M Shaaban; Raji Ganesan

doi:10.1016/j.mpdhp.2020.12.003

Histopathology during the COVID-19 pandemic: resilience through adaptation and innovation

Diagn Histopathol (Oxf). 2021 Mar;27(3):108-115. doi: 10.1016/j.mpdhp.2020.12.003. Epub 2020 Dec 30.

Authors

Tim Bracey^{1

2

3

4

5}, Saimah Arif^{1

2

3

4

5}, Angela Mercy Ralte^{1

2

3

4

5}, Abeer M Shaaban^{1

2

3

4

5}, Raji Ganesan^{1

2

3

4

5}

Affiliations

¹ Consultant Pathologist and Peninsula Clinical Lead, Department of Diagnostic and Molecular Pathology, Royal Cornwall Hospitals NHS Trust, Truro, UK.
² Consultant Pathologist, Princess Alexandra Hospital NHS Trust, Harlow, UK.
³ Consultant Pathologist, The NHS Pathology Centre, Northern Gynaecological Oncology Centre, Queen Elizabeth Hospital, Gateshead, UK.
⁴ Diploma Health Research Consultant Pathologist/Honorary Senior Lecturer, Queen Elizabeth Hospital Birmingham and University of Birmingham, UK.
⁵ Consultant Gynaecological Pathologist, Department of Cellular Pathology, Birmingham Women's and Children's NHS Trust, Birmingham, UK.

Abstract

Histopathology departments have adapted to the challenges posed by the COVID-19 pandemic by a variety of changes including working pattern alterations, technology adoptions and incorporation of techniques. This article summarizes these adaptations and provides references to guide pathologists through the continuing pandemic.

Keywords: COVID reaction; digitalisation; pandemic; remote working; research; training.

Publication types

Review